Expertise in
8
conditions

Munetaka Takekuma

Shizuoka, JP 
Expertise in
8
conditions
Shizuoka, JP 

Overview

Munetaka Takekuma practices practicing medicine in Shizuoka, Japan.

Takekuma is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Cervical Cancer, Febrile Neutropenia, Agranulocytosis, Hysterectomy, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 78 peer reviewed articles and participating in 1 clinical trial.

Locations

Shizuoka, Japan
Other Locations
Shimonagakubo, 4118777, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Enrollment Status: Completed
Publish Date: April 21, 2026
Intervention Type: Drug
Study Drugs: Bevacizumab, Cisplatin, Carboplatin, Paclitaxel, Atezolizumab
Study Phase: Phase 3

78 Total Publications

Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1/JGOG1088S).
Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1/JGOG1088S).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 25, 2026

Frequently Asked Questions about Munetaka Takekuma

Is Munetaka Takekuma a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Munetaka Takekuma is classified as an Distinguished expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Munetaka Takekuma participate in research or clinical trials?

Yes. Munetaka Takekuma has published 78 articles and abstracts on conditions like Cervical Cancer. You can view a list of Munetaka Takekuma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Takekuma's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile